Morgan Stanley Nutri Band Inc. Transaction History

Morgan Stanley

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$3.35 - $6.16 $10,720 - $19,712	3,200 New	3,200 $17,000
Q4 2022 Feb 14, 2023	BUY	$3.53 - $4.5 $1,637 - $2,088	464 New	464 $1,000
Q1 2022 May 13, 2022	SELL	$3.3 - $9.43 $16,414 - $46,904	-4,974 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.14 - $10.08 $15,618 - $50,137	4,974 New	4,974 $50,000

284K

Ticker NTRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,803,260
Market Cap $30.7M
Description
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid the...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.